The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer
Aim: Zinc is a key secondary messenger that can regulate multiple signalling pathways within cancer cells, thus its levels need to be strictly controlled. The Zrt, Irt-like protein (ZIP, SLC39A) family of zinc transporters increase cytosolic zinc from either extracellular or intracellular stores. Th...
Saved in:
Main Authors: | Samuel Jones (Author), Georgia Farr (Author), Thirayost Nimmanon (Author), Silvia Ziliotto (Author), Julia M.W. Gee (Author), Kathryn M. Taylor (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zinc transporter ZnT3/Slc30a3 has a potential role in zinc ion influx in mouse oocytes
by: Atsuko KAGEYAMA, et al.
Published: (2024) -
SLC39A1 contributes to gemcitabine resistance of pancreatic ductal adenocarcinoma by activating AMPK signaling
by: Hao Yu, et al.
Published: (2024) -
Neurosteroid Transport in the Brain: Role of ABC and SLC Transporters
by: Markus Grube, et al.
Published: (2018) -
Loss of slc39a14 causes simultaneous manganese hypersensitivity and deficiency in zebrafish
by: Karin Tuschl, et al.
Published: (2022) -
Characterization of SLC transporters in human skin
by: Marion Alriquet, et al.
Published: (2015)